{"id":"W3014500359","doi":"10.1097/coc.0000000000000691","title":"A Phase 1 Study of SLC-0111, a Novel Inhibitor of Carbonic Anhydrase IX, in Patients With Advanced Solid Tumors","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Enzyme function and inhibition","field":"Biochemistry, Genetics and Molecular Biology","cited_by":250,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; Welichem Biotech (Canada); SignalChem (Canada); Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Sanofi; GlaxoSmithKline; Servier; Pfizer; Eli Lilly and Company; Genentech; PTC Therapeutics; American Association for Cancer Research","keywords":"Medicine; Tolerability; Cmax; Discontinuation; Internal medicine; Pharmacokinetics; Nausea; Adverse effect; Dosing; Cohort; Vomiting; Gastroenterology; Response Evaluation Criteria in Solid Tumors; Pharmacology; Phases of clinical research; Toxicity","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000884605,0.001055409,0.001172442,0.0002745879,0.0003584259,0.0005712539,0.0004784619,0.0008766631,0.002380088],"category_scores_gemma":[0.0005886856,0.0003940159,0.0007713843,0.0002712076,0.0005580442,0.0005171024,0.0002153053,0.0018702,0.0005428168],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006547284,"about_ca_system_score_gemma":0.001504206,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007587727,"about_ca_topic_score_gemma":0.002185865,"domain_scores_codex":[0.9997122,0.0001262255,0.00001177119,0.0000584966,0.00004051794,0.00005080092],"domain_scores_gemma":[0.9994714,0.00007769427,0.0001059473,0.00004008943,0.00005186988,0.000253103],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4173031,0.1218428,0.03008394,0.001439463,0.001612126,0.001231744,0.0008731013,0.007067,0.2406688,0.0004775614,0.01034425,0.1670561],"study_design_scores_gemma":[0.2391961,0.7128725,0.03120582,0.00002902722,0.0003107745,0.0009756791,0.00007092891,0.002240742,0.008685156,0.0001436059,0.004235012,0.00003468303],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962927,0.0006437175,0.0003833922,0.0002269746,0.0000434228,0.001128851,0.0004699087,0.0000466587,0.0007642169],"genre_scores_gemma":[0.9912411,0.001033365,0.001664999,0.0005319798,0.00007502658,0.001292941,0.002158935,0.00002025037,0.001981403],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002380088,"threshold_uncertainty_score":0.007962227,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02776253216202049,"score_gpt":0.3761725389283527,"score_spread":0.3484100067663322,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}